These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787 [TBL] [Abstract][Full Text] [Related]
4. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of community acquired pneumonia]. Drömann D; Schaaf B Pneumologie; 2008 Jul; 62(7):411-9; quiz 420-2. PubMed ID: 18609462 [No Abstract] [Full Text] [Related]
11. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096 [TBL] [Abstract][Full Text] [Related]
12. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians. Rifkin WD; Conner D; Silver A; Eichorn A Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. Smith MJ; Kong M; Cambon A; Woods CR Pediatrics; 2012 May; 129(5):e1326-33. PubMed ID: 22492769 [TBL] [Abstract][Full Text] [Related]
14. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients]. Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ; Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019 [TBL] [Abstract][Full Text] [Related]
15. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance. Asche C; McAdam-Marx C; Seal B; Crookston B; Mullins CD J Antimicrob Chemother; 2008 May; 61(5):1162-8. PubMed ID: 18310136 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic prescribing for CAP in Mexico. Guerrero-Zarraga C; Nava-Ocampo AA Fam Med; 2003 Jun; 35(6):387. PubMed ID: 12817857 [No Abstract] [Full Text] [Related]
17. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)]. Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232 [TBL] [Abstract][Full Text] [Related]